Skip to main content
Displaying 146 of 2825 articles.

A new way to reset gene expression in cancer cells shows promise for leukemia treatment

New findings from Rockefeller University researchers could guide the development of potent combination therapies that deliver more effective and durable treatment of leukemia. In recent work published in Nature, they show it’s possible to deactivate cellular programs involved in tumor growth by d...

Paul Greengard Professorship established with $5 million gift from the Fisher Center Foundation

Late last year, guests at the President’s House raised a glass in celebration of one of Rockefeller’s most beloved colleagues. In his nearly 35 years at Rockefeller, Paul Greengard has led pioneering studies that have transformed our understanding of how the nervous system works, and have paved ...

New research explains why a common bacterium can produce severe illness

As much as we try to avoid it, ­we are constantly sharing germs with those around us. But even when two people have the same infection, the resulting illnesses can be dramatically different—mild for one person, severe or even life-threatening for the other. Now, new research from The Rockefell...

Talking Science lecture introduces students to the genetic aspects of infectious diseases

As he opened this year’s Talking Science lecture, geneticist Jean-Laurent Casanova made a stark observation to his teenage audience: “If we had been here 150 years ago, about half of you would already have died.” The primary reason, he told the 350 high school students and 60 teachers present,...

Mouse studies offer new insights about cocaine’s effect on the brain

 Cocaine is one of the most addictive substances known to man, and for good reason: By acting on levels of the “feel-good” chemical dopamine, it produces a tremendous sensation of euphoria. Now the laboratory of Rockefeller University Professor and Nobel Laureate Paul Greengard has shown...

Researchers develop automated melanoma detector for skin cancer screening

Even experts can be fooled by melanoma. People with this type of skin cancer often have mole-looking growths on their skin that tend to be irregular in shape and color, and can be hard to tell apart from benign ones, making the disease difficult to diagnose. Now, researchers at The Rockefeller Un...

Human embryo discovery wins People’s Choice of Science Breakthrough of the Year

A revolutionary method developed by Rockefeller University scientists that allows researchers to study human embryo development in the lab has been voted Breakthrough of the Year by Science magazine readers. The technique, pioneered by Ali Brivanlou, Robert and Harriet Heilbrunn Professor of the ...

Fifty years after landmark methadone discovery, stigmas and misunderstandings persist

Methadone, the first pharmacological treatment for heroin addiction, was pioneered 50 years ago by Rockefeller University’s Mary Jeanne Kreek and her colleagues. Since then the drug, which is widely used in treatment programs across the globe, has saved countless lives and allowed millions of her...

Jean-Laurent Casanova receives the 2016 Inserm Grand Prix

Jean-Laurent Casanova, professor and head of the St. Giles Laboratory of Human Genetics of Infectious Diseases, has won the 2016 Inserm Grand Prix for his work on the genetic basis of infectious diseases. The prestigious award, given annually by Inserm—the French National Institute of Health and ...

Genomic testing could speed research on skin disease and bring new drugs to patients faster

In an ideal world, the newest and most effective drugs for chronic inflammatory conditions would immediately help everyone who took them. Unfortunately, in the real world, it can take several months to determine whether a given patient will respond to one of these medications, which target specif...